tiprankstipranks
Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh (AU:DOC)
ASX:DOC
Australian Market

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh (DOC) AI Stock Analysis

4 Followers

Top Page

AU:DOC

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh

(Sydney:DOC)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
AU$0.13
▼(-6.43% Downside)
Action:ReiteratedDate:03/26/26
The score is driven primarily by improving financial performance (turnaround to profits and strong free cash flow), but it is held back by significant balance-sheet leverage risk and weak technical trend signals. Valuation appears reasonable but not compelling without dividend support.
Positive Factors
Improved Cash Generation
Significant cash flow recovery in 2025 demonstrates the business can convert revenue into cash, improving liquidity and the ability to fund operations, invest in the platform, or reduce reliance on external financing. Sustained FCF would materially strengthen financial flexibility and support growth initiatives.
Negative Factors
High Leverage
Debt-to-equity around 10.2x and prior negative equity create a fragile capital structure with limited cushion. High leverage raises refinancing and interest-service risk, constrains capital allocation for product investment or M&A, and makes the business vulnerable to any weaker cash flows or revenue setbacks.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved Cash Generation
Significant cash flow recovery in 2025 demonstrates the business can convert revenue into cash, improving liquidity and the ability to fund operations, invest in the platform, or reduce reliance on external financing. Sustained FCF would materially strengthen financial flexibility and support growth initiatives.
Read all positive factors

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh (DOC) vs. iShares MSCI Australia ETF (EWA)

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Business Overview & Revenue Model

Company Description
Doctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland. It offers services in the areas of appointments, patient records, p...
How the Company Makes Money
Doctor Care Anywhere Group PLC generates revenue primarily through subscription fees and usage-based charges for its telehealth services. Its clients include individual patients, corporate customers, and insurance companies that offer the platform...

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Financial Statement Overview

Summary
Operationally improved in 2025 with a return to profitability and strong positive operating/free cash flow, but balance-sheet risk is high (very elevated leverage and previously negative equity). Margins are still thin and revenue growth is uneven.
Income Statement
62
Positive
Balance Sheet
28
Negative
Cash Flow
74
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue38.43M39.33M38.46M29.31M24.96M
Gross Profit14.12M22.42M17.69M13.42M10.40M
EBITDA4.21M-2.15M-5.78M-16.95M-18.92M
Net Income1.17M-6.29M-10.05M-22.03M-20.22M
Balance Sheet
Total Assets17.18M14.99M19.61M22.01M19.69M
Cash, Cash Equivalents and Short-Term Investments6.56M5.29M8.10M5.41M17.07M
Total Debt10.39M8.27M11.00M1.59M1.35M
Total Liabilities16.16M15.64M17.27M9.72M3.86M
Stockholders Equity1.02M-645.00K2.33M12.29M15.82M
Cash Flow
Free Cash Flow4.85M347.00K-8.67M-24.38M-10.10M
Operating Cash Flow4.92M353.00K-6.34M-22.03M-8.65M
Investing Cash Flow-2.29M-1.65M-2.24M-2.34M-2.42M
Financing Cash Flow-428.87K-332.00K9.32M5.90M-611.00K

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.14
Price Trends
50DMA
0.15
Negative
100DMA
0.14
Negative
200DMA
0.15
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
48.01
Neutral
STOCH
62.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DOC, the sentiment is Neutral. The current price of 0.14 is above the 20-day moving average (MA) of 0.14, below the 50-day MA of 0.15, and below the 200-day MA of 0.15, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 48.01 is Neutral, neither overbought nor oversold. The STOCH value of 62.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:DOC.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
52
Neutral
AU$49.50M24.60250.55%-6.86%51.88%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
43
Neutral
AU$69.51M-6.64-59.96%
43
Neutral
AU$38.71M-4.21-52.26%-36.68%79.41%
43
Neutral
AU$30.31M-3.13-1009.84%25.98%22.10%
41
Neutral
AU$3.94M-1.9820.02%-9.90%34.07%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:DOC
Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh
0.14
0.05
56.98%
AU:GLH
Global Health Limited
0.07
-0.04
-39.09%
AU:SHG
Singular Health Group Ltd
0.22
0.02
7.32%
AU:EMD
Emyria Ltd
0.05
0.02
65.52%
AU:PCK
PainChek Ltd
0.15
-0.15
-51.51%

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Corporate Events

Doctor Care Anywhere Sets April Date and Hybrid Format for 2026 AGM
Mar 29, 2026
Doctor Care Anywhere Group Plc has called its 2026 Annual General Meeting for 28 April 2026, offering both a physical venue in Melbourne and an online participation option for securityholders. Shareholders and CDI holders will be able to view the ...
Doctor Care Anywhere Files Governance Statement and ASX Appendix 4G
Mar 25, 2026
Doctor Care Anywhere Group Plc has released its corporate governance statement for the financial year ended 31 December 2025, confirming that it is included in the company’s annual report and has been approved by the board as accurate and cu...
Doctor Care Anywhere Sets Date for 2026 AGM and Highlights Growth-Focused Telehealth Strategy
Mar 5, 2026
Doctor Care Anywhere Group PLC has scheduled its 2026 Annual General Meeting for Tuesday, 28 April 2026, in line with ASX listing requirements and under the authority of its board and company secretary. The company is also directing investors to i...
Doctor Care Anywhere Delivers First Annual Profit as Digital Health Platform Expands
Feb 24, 2026
Doctor Care Anywhere reported a strong turnaround for 2025, delivering its first positive earnings per share as revenue rose 6.5% to £38 million and underlying EBITDA climbed to £5.3 million, a 13.9% margin. Net profit reached £1.2 ...
Doctor Care Anywhere Posts Strong Cashflow and Rising Patient Engagement in Q4 2025
Jan 28, 2026
Doctor Care Anywhere reported renewed consultation growth in the second half of 2025, with volumes up 3.4% and consistently above 2024 levels since May, supported by a 7.9% year-on-year increase in activated lives to 1.3 million and a rise in repe...
Doctor Care Anywhere Sets Date for Q4 2025 Activity and Cash Flow Update
Jan 23, 2026
Doctor Care Anywhere Group PLC has announced that it will release its Appendix 4C quarterly cash flow and activity report for the fourth quarter of 2025 on 29 January 2026, providing an update on the company’s recent operational and financia...
Doctor Care Anywhere Director Increases Stake via On-Market Purchase
Jan 14, 2026
Doctor Care Anywhere Group PLC has disclosed that director John Stier increased his direct holding in the company by acquiring 500,000 ordinary fully paid CHESS Depositary Interests on-market, lifting his stake from 3.5 million to 4 million securi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 26, 2026